News

Gujarat Kidney IPO Day 2 LIVE: The initial public offering (IPO) of Gujarat Kidney and Super Speciality entered its second day of bidding today, December 23, following a good response on its first day (December 22). Investors have two more days to apply for the IPO, with the offer slated to close on December 24.

At the end of the first day, investors applied for about 1.47 times the number of shares available.

₹251-crore Gujarat Kidney IPO price band has been fixed at ₹108 and ₹114 per share. This IPO is a fresh issue, meaning all shares are newly issued by the company. A total of 2.2 crore shares are being offered. The money raised will be used to buy Parekhs Hospital in Ahmedabad, part fund the cost for Ashwini Medical Centre, which was already acquired, build a new hospital in Vadodara, buy robotic medical equipment, repay loans, and support future hospital acquisitions and general business needs.

The grey market premium (GMP) for Gujarat Kidney IPO has declined. Gujarat Kidney IPO GMP today is ₹4 as against ₹7 earlier. At the current GMP, Gujarat Kidney IPO listing price could be ₹118, a premium of 3.5% against the IPO price.

Gujarat Kidney and Super Speciality is a regional healthcare company based in Gujarat. It runs seven mid-sized multi-speciality hospitals with a total of 490 beds, offering advanced healthcare services.

Watch this space for LIVE updates on Gujarat Kidney IPO Day 2 updates.

Gujarat Kidney IPO booked 1.92 times so far. Here's how different quotas were booked:

QIB: 34%

NII: 2.24x

Retail: 6.99x

Gujarat Kidney and Super Speciality Limited has grown its scale and profitability on the back of an asset-heavy but efficient hospital model, with improving margins driven by better case mix, higher occupancy, and operating leverage from its existing infrastructure.

The entire ₹250.80 Cr (100%) IPO is a Fresh Issue, with zero Offer for Sale (OFS), signalling strong promoter confidence. Approximately ₹77 Cr is earmarked for the landmark acquisition of Parekhs Hospital in Ahmedabad, while ₹30 Cr will fund a new greenfield Women’s Hospital in Vadodara. Additional funds are allocated for robotic surgical equipment and increasing stakes in high-performing subsidiaries.

Despite the competitive nature of the healthcare sector, Gujarat Kidney’s asset-light integration model and its dominance in the renal care niche allow it to capitalize on the rising demand for quality healthcare in semi-urban India. We recommend a ‘SUBSCRIBE’ rating for long-term investors.

— Anshul Jain, Lakshmishree

Gujarat Kidney IPO's second day of bidding kicked off at 10 am today. Investors can place the bids till 5 pm today. As of the first day, the IPO was booked 1.47 times, eliciting strong response from NII and retail investors.

The initial public offering of healthcare company Gujarat Kidney and Super Speciality Ltd received 1.47 times subscription on the first day of share sale on Monday.

The IPO received bids for 1,94,25,792 shares against 1,32,26,880 shares on offer, according to NSE data. The category for Retail Individual Investors (RIIs) fetched 4.69 times subscription, while the quota for non-institutional investors got subscribed 1.96 times. The category for Qualified Institutional Buyers (QIBs) received 34 per cent subscription.

The grey market premium (GMP) for Gujarat Kidney IPO has declined. Gujarat Kidney IPO GMP today is ₹4 as against ₹7 earlier. At the current GMP, Gujarat Kidney IPO listing price could be ₹118, a premium of 3.5% against the IPO price.

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Download the Mint app and read premium stories

Log in to our website to save your bookmarks. It'll just take a moment.

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.